Karp Capital Management’s iShares US Medical Devices ETF IHI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-121,633
Closed -$5.74M 50
2022
Q3
$5.74M Sell
121,633
-8,482
-7% -$440K 1.17% 32
2022
Q2
$6.56M Sell
130,115
-24,453
-16% -$1.33M 1.16% 30
2022
Q1
$9.42M Sell
154,568
-107,085
-41% -$6.38M 1.37% 25
2021
Q4
$17.2M Buy
261,653
+12,650
+5% +$810K 2.16% 6
2021
Q3
$15.6M Buy
249,003
+2,451
+1% +$156K 2.2% 5
2021
Q2
$14.8M Buy
246,552
+6,480
+3% +$375K 2.2% 4
2021
Q1
$13.2M Buy
240,072
+11,286
+5% +$626K 2.39% 6
2020
Q4
$12.5M Sell
228,786
-666
-0.3% -$34.8K 2.57% 4
2020
Q3
$11.5M Sell
229,452
-11,862
-5% -$574K 2.8% 3
2020
Q2
$10.6M Buy
241,314
+8,094
+3% +$346K 2.95% 6
2020
Q1
$8.76M Buy
233,220
+4,746
+2% +$200K 2.87% 5
2019
Q4
$10.1M Buy
228,474
+990
+0.4% +$41.6K 2.65% 4
2019
Q3
$9.37M Buy
227,484
+2,490
+1% +$102K 2.73% 4
2019
Q2
$9.03M Buy
224,994
+15,960
+8% +$604K 2.86% 2
2019
Q1
$8.07M Sell
209,034
-5,538
-3% -$201K 2.87% 2
2018
Q4
$7.15M Buy
214,572
+7,074
+3% +$245K 3.41% 1
2018
Q3
$7.87M Buy
207,498
+22,410
+12% +$796K 2.71% 2
2018
Q2
$6.19M Buy
185,088
+18,660
+11% +$608K 2.44% 7
2018
Q1
$5.13M Buy
166,428
+13,350
+9% +$411K 2.07% 11
2017
Q4
$4.43M Buy
153,078
+6,414
+4% +$185K 1.87% 14
2017
Q3
$4.08M Sell
146,664
-5,964
-4% -$165K 1.9% 15
2017
Q2
$4.24M Buy
152,628
+3,990
+3% +$106K 2.1% 12
2017
Q1
$3.75M Sell
148,638
-120
-0.1% -$2.91K 2.12% 11
2016
Q4
$3.3M Buy
148,758
+1,356
+0.9% +$30.8K 2.18% 15
2016
Q3
$3.57M Sell
147,402
-8,766
-6% -$209K 2.28% 13
2016
Q2
$3.53M Buy
156,168
+16,242
+12% +$352K 2.35% 11
2016
Q1
$2.86M Buy
139,926
+8,316
+6% +$161K 1.97% 17
2015
Q4
$2.69M Buy
+131,610
New +$2.63M 1.56% 26

Other funds holding IHI

Karp Capital Management's IHI Position: Q4 2022 in Review

Karp Capital Management sold out of iShares US Medical Devices ETF (IHI) in Q4 2022, closing a stake of 121,633 shares — an estimated $5.74M sold.

Karp Capital Management first reported a position in IHI in Q4 2015 and held it in 28 quarters. The position peaked at $17.2M in Q4 2021. 577 funds tracked by Wall St. Rank hold IHI as of Q4 2022.

  • Karp Capital Management reported no remaining iShares US Medical Devices ETF position as of Q4 2022 after selling out during the quarter.
  • Karp Capital Management sold 121,633 iShares US Medical Devices ETF shares in Q4 2022, an estimated $5.74M.
  • Karp Capital Management first reported a position in iShares US Medical Devices ETF in Q4 2015 and held it in 28 quarters.
  • Karp Capital Management's iShares US Medical Devices ETF position peaked at $17.2M in Q4 2021.
  • 577 funds tracked by Wall St. Rank held iShares US Medical Devices ETF as of Q4 2022.

Based on Karp Capital Management's 13F filing for Q4 2022.